Publicaciones (17) Publicaciones en las que ha participado algún/a investigador/a

2001

  1. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents.

    Current medicinal chemistry. Anti-cancer agents, Vol. 1, Núm. 3, pp. 257-276

  2. Comparative binding energy (COMBINE) analysis of human neutrophil elastase inhibition by pyridone-containing trifluoromethylketones

    Combinatorial Chemistry and High Throughput Screening, Vol. 4, Núm. 8, pp. 627-642

  3. Comparative binding energy analysis of the substrate specificity of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10

    Biochemistry, Vol. 40, Núm. 30, pp. 8905-8917

  4. Composición de la fracción péctica de las frutas: ácidos urónicos y azúcares

    Alimentaria: Revista de tecnología e higiene de los alimentos, Núm. 324, pp. 67-72

  5. Correlation of in vitro and in vivo acetaminophen availability from albumin microaggregates oral modified release formulations

    International Journal of Pharmaceutics, Vol. 217, Núm. 1-2, pp. 193-199

  6. Cyclosporine-loaded polycaprolactone nanoparticles: Immunosuppression and nephrotoxicity in rats

    European Journal of Pharmaceutical Sciences, Vol. 12, Núm. 4, pp. 471-478

  7. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats

    Pharmazie, Vol. 56, Núm. 1, pp. 78-82

  8. Exploring the role of the 5′-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives

    Antiviral Research, Vol. 50, Núm. 3, pp. 207-222

  9. Identification of a putative binding site for [2′,5′-Bis-O-(tert-butyldimethylsilyl) -β-D-ribofuranosyl]-3′-spiro-5″- (4″-amino-1″,2″-oxathiole-2″,2″-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase

    Journal of Medicinal Chemistry, Vol. 44, Núm. 12, pp. 1853-1865

  10. Iridoids from Scrophularia genus

    Zeitschrift fur Naturforschung - Section C Journal of Biosciences, Vol. 56, Núm. 7-8, pp. 513-520

  11. La declaración de helsinki VI: Una revisión necesaria, pero ¿suficiente?

    Revista Espanola de Salud Publica, Vol. 75, Núm. 5, pp. 407-419

  12. Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity

    Planta Medica, Vol. 67, Núm. 3, pp. 219-223

  13. Mechanisms involved in the relaxation of bovine aortic endothelial cells

    Life Sciences, Vol. 70, Núm. 6, pp. 699-714

  14. Molecular dynamics simulations of the conformational changes of the glutamate receptor ligand-binding core in the presence of glutamate and kainate

    Proteins: Structure, Function and Genetics, Vol. 44, Núm. 4, pp. 460-469

  15. Phytochemical Analysis of Phillyrea latifolia L., A New Source of Oleuropeoside

    Zeitschrift fur Naturforschung - Section C Journal of Biosciences, Vol. 56, Núm. 5-6, pp. 353-356

  16. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

    BMC Clinical Pharmacology, Vol. 1

  17. Uso racional de recursos

    Medicina Clinica, Vol. 117, Núm. 17, pp. 662-675